Analysts Set Smith & Nephew plc (LON:SN) PT at GBX 1,382.63

Smith & Nephew plc (LON:SN) has earned a consensus rating of “Hold” from the eight research firms that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is GBX 1,382.63.

A number of brokerages recently weighed in on SN. Berenberg Bank restated a “hold” rating and set a GBX 13 target price on shares of Smith & Nephew in a research report on Friday, May 1st. Jefferies Financial Group reiterated a “buy” rating and set a GBX 2,760 price objective on shares of Smith & Nephew in a research report on Thursday, May 21st. UBS Group reiterated a “neutral” rating and set a GBX 1,300 price objective on shares of Smith & Nephew in a research report on Tuesday, May 5th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and set a GBX 1,350 price objective on shares of Smith & Nephew in a research report on Wednesday.

Smith & Nephew Stock Performance

Shares of LON:SN opened at GBX 1,133 on Monday. The company has a current ratio of 2.57, a quick ratio of 0.84 and a debt-to-equity ratio of 62.90. The stock’s fifty day moving average is GBX 1,161.09 and its two-hundred day moving average is GBX 1,220.20. The company has a market capitalization of £12.42 billion, a price-to-earnings ratio of 40.79, a price-to-earnings-growth ratio of 0.46 and a beta of 0.67.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.